Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,360 | 261 | 96.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $95.00 | 1 | 2.7% |
| Education | $43.29 | 4 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $430.95 | 82 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $422.81 | 30 | $0 (2020) |
| Novo Nordisk Inc | $382.79 | 23 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $328.15 | 25 | $0 (2020) |
| Allergan Inc. | $301.95 | 12 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $276.82 | 16 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $207.17 | 13 | $0 (2022) |
| Lilly USA, LLC | $192.85 | 13 | $0 (2019) |
| Amgen Inc. | $186.93 | 12 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $168.00 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $38.39 | 2 | ABBVIE INC. ($22.09) |
| 2022 | $217.45 | 12 | Takeda Pharmaceuticals U.S.A., Inc. ($156.24) |
| 2020 | $288.62 | 16 | Novo Nordisk Inc ($59.23) |
| 2019 | $1,056 | 76 | Novo Nordisk Inc ($220.92) |
| 2018 | $879.55 | 79 | Boehringer Ingelheim Pharmaceuticals, Inc. ($134.93) |
| 2017 | $1,018 | 81 | Allergan Inc. ($211.87) |
All Payment Transactions
266 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/18/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: RESPIRATORY | ||||||
| 03/01/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $0.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Diabetes | ||||||
| 07/01/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Diabetes | ||||||
| 01/27/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: NEUROSCIENCE | ||||||
| 01/04/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/10/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.55 | General |
| 02/25/2020 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: VACCINES | ||||||
| 02/21/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: GASTROINTESTINAL | ||||||
| 02/20/2020 | PFIZER INC. | CHANTIX (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/13/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: NEUROSCIENCE | ||||||
| 02/11/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Diabetes | ||||||
| 02/06/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/30/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/28/2020 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: VACCINE | ||||||
| 01/23/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 875 | 1,011 | $206,514 | $67,177 |
| 2022 | 14 | 865 | 999 | $210,149 | $66,830 |
| 2021 | 14 | 671 | 807 | $184,741 | $58,281 |
| 2020 | 12 | 812 | 969 | $166,608 | $53,308 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 172 | 283 | $87,940 | $24,111 | 27.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 132 | 132 | $41,420 | $16,596 | 40.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 93 | $20,509 | $5,765 | 28.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 101 | 101 | $20,563 | $5,674 | 27.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $8,320 | $3,390 | 40.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 131 | 131 | $5,903 | $2,319 | 39.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 119 | 119 | $5,355 | $2,106 | 39.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $4,433 | $1,780 | 40.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $4,433 | $1,777 | 40.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 23 | 23 | $2,415 | $1,579 | 65.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $1,145 | $695.52 | 60.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 13 | 16 | $2,000 | $604.80 | 30.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $713.00 | $423.36 | 59.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 27 | 28 | $980.00 | $240.94 | 24.6% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 11 | 11 | $385.00 | $115.19 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 168 | 282 | $90,240 | $23,769 | 26.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 130 | 130 | $42,380 | $16,749 | 39.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 113 | 113 | $24,069 | $6,218 | 25.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 71 | $16,117 | $4,465 | 27.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 14 | 14 | $8,960 | $3,891 | 43.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 141 | 141 | $6,486 | $2,565 | 39.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 127 | 127 | $5,715 | $2,271 | 39.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 12 | 12 | $5,028 | $1,981 | 39.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $4,609 | $1,814 | 39.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 16 | 16 | $1,680 | $1,097 | 65.3% |
About Dr. Danny Fox, M.D
Dr. Danny Fox, M.D is a Family Medicine healthcare provider based in Oldsmar, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568416816.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danny Fox, M.D has received a total of $3,498 in payments from pharmaceutical and medical device companies, with $38.39 received in 2023. These payments were reported across 266 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,360).
As a Medicare-enrolled provider, Fox has provided services to 3,223 Medicare beneficiaries, totaling 3,786 services with total Medicare billing of $245,595. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Oldsmar, FL
- Active Since 05/20/2006
- Last Updated 08/15/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1568416816
Products in Payments
- FARXIGA (Drug) $320.68
- JANUVIA (Drug) $179.61
- TRINTELLIX (Drug) $156.24
- NAMENDA XR (Drug) $139.42
- Ozempic (Drug) $133.99
- SOLIQUA (Drug) $132.49
- JARDIANCE (Drug) $124.25
- CHANTIX (Drug) $111.01
- Tresiba (Drug) $102.56
- Prolia (Biological) $98.10
- LYRICA (Drug) $94.99
- INVOKANA (Drug) $91.53
- XIFAXAN (Drug) $91.08
- ELIQUIS (Drug) $89.71
- TRULICITY (Drug) $77.98
- SYMBICORT (Drug) $71.32
- BASAGLAR (Drug) $70.90
- PREVNAR - 13 (Biological) $66.21
- TRADJENTA (Drug) $65.32
- ZOSTAVAX (Biological) $64.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Oldsmar
Howard Chipman, M.d, M.D
Family Medicine — Payments: $69,441
Dr. Juan Falla, M.d, M.D
Family Medicine — Payments: $3,116
Dr. David Hughes, M.d, M.D
Family Medicine — Payments: $2,549
Robert Dimasi, D.o, D.O
Family Medicine — Payments: $772.14
Annie Thomas, Md, MD
Family Medicine — Payments: $495.26
Naxdaris Gonzalez, Md, MD
Family Medicine